Effect of a Video-based Information Intervention on Family Outcomes in Neurocritical Care (WELFARE)

November 13, 2026 updated by: University Hospital, Caen

Effect of a Video-based Information Intervention on Family Outcomes in Neurocritical Care: Study Protocol for the WELl-being of FAmily in Neurocritical caRE Unit (*WELFARE*) Randomised Controlled Trial

The trial was designed to determine whether on-demand access to educational videos about neurocritical care, in addition to usual family support, reduces the prevalence of post-traumatic stress symptoms among relatives 3 months after intensive care unit admission. The expected finding is a lower prevalence of post-traumatic stress symptoms among relatives given access to the videos.

Study Overview

Detailed Description

This study is a superiority trial. Relatives are randomly assigned in a 1:1 ratio to the control or intervention group, using permuted blocks of variable size.

Study Type

Interventional

Enrollment (Estimated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 14033
        • Caen University Hospital (CHU de Caen Normandie)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary relative of a patient admitted to an adult intensive care unit for a traumatic brain injury or a stroke (haemorrhagic or ischaemic).
  • The primary relative is designated according to the following order of priority: the trusted person (personne de confiance) or, failing that, the designated family member or, failing that, the designated close person.
  • Age of the primary relative greater than or equal to 18 years.
  • The primary relative is not under legal guardianship.
  • French-speaking primary relative.
  • Primary relative affiliated with a social security scheme.
  • Primary relative who has signed an informed consent form.

Exclusion Criteria:

  • Primary relative under 18 years of age
  • Psychiatric disorder under drug treatment
  • Non-French-speaking primary relative
  • Refusal to participate in the study by the primary relative
  • Primary relative not affiliated with a social security scheme
  • The primary relative is a pregnant woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual family support

At inclusion, the unit's paper welcome booklet is given to relatives during a family meeting with a physician, the nurse and the nursing assistant in charge of the patient. The team answers their questions, explains the patient's condition, treatment and prognosis, and presents the unit's visiting and appointment policy. During the stay, meetings are organised to review the patient's condition, diagnosis, prognosis and treatment, according to unit practice. Visits, telephone calls and meetings with the healthcare team are free, limited only by the unit's visiting rules and staff availability.

Experimental: Usual family support plus access to the educational videos

At inclusion, the unit's paper welcome booklet is given to relatives during a family meeting with a physician, the nurse and the nursing assistant in charge of the patient. The team answers their questions, explains the patient's condition, treatment and prognosis, and presents the unit's visiting and appointment policy. During the stay, meetings are organised to review the patient's condition, diagnosis, prognosis and treatment, according to unit practice. Visits, telephone calls and meetings with the healthcare team are free, limited only by the unit's visiting rules and staff availability.

The videos were produced by the unit's healthcare professionals. Access is free and unlimited, on demand, on a secure website, throughout the patient's intensive care unit stay. They retrace the chronology of the care pathway of a neurocritical care patient and answer questions frequently asked by families during meetings with the team, for example about the patient's room and environment, the equipment used, the staff, and the procedures performed and their purpose.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of post-traumatic stress symptoms
Time Frame: 3 months

Post-traumatic stress symptoms is defined as an Impact of Event Scale-Revised total score above 30. The Impact of Event Scale-Revised is a 22-item self-report questionnaire measuring subjective distress caused by a traumatic event (total score 0-88).

3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family satisfaction
Time Frame: 3 month

Family satisfaction is measured with the Family Satisfaction in the Intensive Care Unit questionnaire. It evaluates two main areas: satisfaction with patient care and satisfaction with communication and decision-making involving healthcare professionals.

3 month
Depressive symptoms
Time Frame: 3 month

Depressive symptoms are defined as a Hospital Anxiety and Depression Scale depression subscore above 7. It is a validated self-report questionnaire. It consists of seven items assessing feelings such as loss of enjoyment, reduced interest and decreased motivation over the previous week, with scores ranging from 0 to 21.

3 month
Anxiety symptoms
Time Frame: 3 months

Anxiety symptoms are defined as a Hospital Anxiety and Depression Scale anxiety subscore above 7. It is a validated self-report questionnaire. It consists of seven items assessing feelings of anxiety and worry over the previous week, with scores ranging from 0 to 21.

3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

February 1, 2029

Study Completion (Estimated)

February 1, 2029

Study Registration Dates

First Submitted

November 6, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe